JAMES H DAVIS Insider Trading $HGSI HUMAN GENOME SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES H DAVIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES H DAVIS. JAMES H DAVIS is Exec. VP, Gen Counsel & Sec. in HUMAN GENOME SCIENCES INC ($HGSI) and Sr. VP, Gen. Counsel & Sec. in HUMAN GENOME SCIENCES INC ($HGSI).
JAMES H DAVIS in HUMAN GENOME SCIENCES INC
Trading Symbol: HGSIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES H DAVIS: Exec. VP, Gen Counsel & Sec., Sr. VP, Gen. Counsel & Sec.
Holdings: 0 shares
Latest Transaction: Aug 01 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES H DAVIS in HUMAN GENOME SCIENCES INC
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.71 | 1,050 | 11,246 | 112,690 | 113.7 K to 112.7 K (-0.92 %) |
Apr 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.72 | 800 | 8,576 | 113,740 | 114.5 K to 113.7 K (-0.70 %) |
Apr 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.74 | 400 | 4,296 | 114,540 | 114.9 K to 114.5 K (-0.35 %) |
Apr 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.76 | 400 | 4,304 | 114,940 | 115.3 K to 114.9 K (-0.35 %) |
Apr 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.77 | 200 | 2,154 | 115,340 | 115.5 K to 115.3 K (-0.17 %) |
Apr 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 115,540 | 88 K to 115.5 K (+31.24 %) |
Mar 21 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 20,040 | 137,074 | 64,460 | |
Mar 21 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 20,040 | 137,074 | 88,040 | 68 K to 88 K (+29.47 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 84,500 | |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.23 | 7,000 | 71,610 | 68,000 | 75 K to 68 K (-9.33 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.24 | 2,500 | 25,600 | 75,000 | 77.5 K to 75 K (-3.23 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.25 | 1,900 | 19,475 | 77,500 | 79.4 K to 77.5 K (-2.39 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.26 | 3,000 | 30,780 | 79,400 | 82.4 K to 79.4 K (-3.64 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.27 | 2,645 | 27,164 | 82,400 | 85 K to 82.4 K (-3.11 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.28 | 1,325 | 13,621 | 85,045 | 86.4 K to 85 K (-1.53 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.29 | 904 | 9,302 | 86,370 | 87.3 K to 86.4 K (-1.04 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.30 | 3,511 | 36,163 | 87,274 | 90.8 K to 87.3 K (-3.87 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.31 | 1,300 | 13,403 | 90,785 | 92.1 K to 90.8 K (-1.41 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.32 | 700 | 7,224 | 92,085 | 92.8 K to 92.1 K (-0.75 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.33 | 300 | 3,099 | 92,785 | 93.1 K to 92.8 K (-0.32 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.34 | 1,500 | 15,510 | 93,085 | 94.6 K to 93.1 K (-1.59 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.35 | 215 | 2,225 | 94,585 | 94.8 K to 94.6 K (-0.23 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.36 | 500 | 5,180 | 94,800 | 95.3 K to 94.8 K (-0.52 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.37 | 100 | 1,037 | 95,300 | 95.4 K to 95.3 K (-0.10 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.38 | 100 | 1,038 | 95,400 | 95.5 K to 95.4 K (-0.10 %) |
Mar 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 95,500 | 68 K to 95.5 K (+40.44 %) |
Mar 13 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | A | 10.62 | 130,000 | 1,380,600 | 130,000 | |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 112,000 | |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.54 | 988 | 10,414 | 68,000 | 69 K to 68 K (-1.43 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.55 | 212 | 2,237 | 68,988 | 69.2 K to 69 K (-0.31 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.58 | 4,200 | 44,436 | 69,200 | 73.4 K to 69.2 K (-5.72 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.59 | 1,748 | 18,511 | 73,400 | 75.1 K to 73.4 K (-2.33 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.60 | 3,300 | 34,980 | 75,148 | 78.4 K to 75.1 K (-4.21 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.61 | 6,700 | 71,087 | 78,448 | 85.1 K to 78.4 K (-7.87 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.62 | 648 | 6,882 | 85,148 | 85.8 K to 85.1 K (-0.76 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.63 | 600 | 6,378 | 85,796 | 86.4 K to 85.8 K (-0.69 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.64 | 1,200 | 12,768 | 86,396 | 87.6 K to 86.4 K (-1.37 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.65 | 1,400 | 14,910 | 87,596 | 89 K to 87.6 K (-1.57 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.66 | 570 | 6,076 | 88,996 | 89.6 K to 89 K (-0.64 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.67 | 1,300 | 13,871 | 89,566 | 90.9 K to 89.6 K (-1.43 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.69 | 200 | 2,138 | 90,866 | 91.1 K to 90.9 K (-0.22 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.72 | 4,380 | 46,954 | 91,066 | 95.4 K to 91.1 K (-4.59 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.73 | 20 | 215 | 95,446 | 95.5 K to 95.4 K (-0.02 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 10.83 | 34 | 368 | 95,466 | 95.5 K to 95.5 K (-0.04 %) |
Mar 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 95,500 | 68 K to 95.5 K (+40.44 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 139,500 | |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.29 | 600 | 6,774 | 68,000 | 68.6 K to 68 K (-0.87 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.30 | 1,000 | 11,300 | 68,600 | 69.6 K to 68.6 K (-1.44 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.31 | 575 | 6,503 | 69,600 | 70.2 K to 69.6 K (-0.82 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.32 | 200 | 2,264 | 70,175 | 70.4 K to 70.2 K (-0.28 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.33 | 1,000 | 11,330 | 70,375 | 71.4 K to 70.4 K (-1.40 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.34 | 2,600 | 29,484 | 71,375 | 74 K to 71.4 K (-3.51 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.35 | 500 | 5,675 | 73,975 | 74.5 K to 74 K (-0.67 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.36 | 1,000 | 11,360 | 74,475 | 75.5 K to 74.5 K (-1.32 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.37 | 1,400 | 15,918 | 75,475 | 76.9 K to 75.5 K (-1.82 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.38 | 1,600 | 18,208 | 76,875 | 78.5 K to 76.9 K (-2.04 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.39 | 600 | 6,834 | 78,475 | 79.1 K to 78.5 K (-0.76 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.40 | 7,600 | 86,640 | 79,075 | 86.7 K to 79.1 K (-8.77 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.41 | 2,400 | 27,384 | 86,675 | 89.1 K to 86.7 K (-2.69 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.42 | 1,100 | 12,562 | 89,075 | 90.2 K to 89.1 K (-1.22 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.43 | 900 | 10,287 | 90,175 | 91.1 K to 90.2 K (-0.99 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.44 | 1,300 | 14,872 | 91,075 | 92.4 K to 91.1 K (-1.41 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.45 | 1,400 | 16,030 | 92,375 | 93.8 K to 92.4 K (-1.49 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.46 | 300 | 3,438 | 93,775 | 94.1 K to 93.8 K (-0.32 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.47 | 700 | 8,029 | 94,075 | 94.8 K to 94.1 K (-0.74 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.48 | 725 | 8,323 | 94,775 | 95.5 K to 94.8 K (-0.76 %) |
Feb 16 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 95,500 | 68 K to 95.5 K (+40.44 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 167,000 | |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.75 | 6,300 | 74,025 | 68,000 | 74.3 K to 68 K (-8.48 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.76 | 3,300 | 38,808 | 74,300 | 77.6 K to 74.3 K (-4.25 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.77 | 500 | 5,885 | 77,600 | 78.1 K to 77.6 K (-0.64 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.77 | 4,600 | 54,142 | 78,100 | 82.7 K to 78.1 K (-5.56 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.78 | 7,005 | 82,519 | 82,700 | 89.7 K to 82.7 K (-7.81 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.79 | 2,295 | 27,058 | 89,705 | 92 K to 89.7 K (-2.49 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.80 | 1,700 | 20,060 | 92,000 | 93.7 K to 92 K (-1.81 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.81 | 700 | 8,267 | 93,700 | 94.4 K to 93.7 K (-0.74 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.82 | 1,000 | 11,820 | 94,400 | 95.4 K to 94.4 K (-1.05 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 11.83 | 100 | 1,183 | 95,400 | 95.5 K to 95.4 K (-0.10 %) |
Feb 02 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 95,500 | 68 K to 95.5 K (+40.44 %) |
Jan 25 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 15,000 | 102,600 | 194,500 | |
Jan 25 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 15,000 | 102,600 | 68,000 | 53 K to 68 K (+28.30 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 209,500 | |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.31 | 1,900 | 23,389 | 53,000 | 54.9 K to 53 K (-3.46 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.32 | 3,400 | 41,888 | 54,900 | 58.3 K to 54.9 K (-5.83 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.33 | 2,500 | 30,825 | 58,300 | 60.8 K to 58.3 K (-4.11 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.34 | 10,300 | 127,102 | 60,800 | 71.1 K to 60.8 K (-14.49 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.35 | 4,600 | 56,810 | 71,100 | 75.7 K to 71.1 K (-6.08 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.36 | 1,800 | 22,248 | 75,700 | 77.5 K to 75.7 K (-2.32 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.37 | 1,800 | 22,266 | 77,500 | 79.3 K to 77.5 K (-2.27 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.38 | 1,100 | 13,618 | 79,300 | 80.4 K to 79.3 K (-1.37 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.39 | 100 | 1,239 | 80,400 | 80.5 K to 80.4 K (-0.12 %) |
Jan 19 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 80,500 | 53 K to 80.5 K (+51.89 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 237,000 | |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.20 | 200 | 2,440 | 53,000 | 53.2 K to 53 K (-0.38 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.21 | 300 | 3,663 | 53,200 | 53.5 K to 53.2 K (-0.56 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.22 | 600 | 7,332 | 53,500 | 54.1 K to 53.5 K (-1.11 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.23 | 1,589 | 19,433 | 54,100 | 55.7 K to 54.1 K (-2.85 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.24 | 1,815 | 22,216 | 55,689 | 57.5 K to 55.7 K (-3.16 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.25 | 900 | 11,025 | 57,504 | 58.4 K to 57.5 K (-1.54 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.26 | 1,547 | 18,966 | 58,404 | 60 K to 58.4 K (-2.58 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.27 | 3,153 | 38,687 | 59,951 | 63.1 K to 60 K (-5.00 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.28 | 1,600 | 19,648 | 63,104 | 64.7 K to 63.1 K (-2.47 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.29 | 400 | 4,916 | 64,704 | 65.1 K to 64.7 K (-0.61 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.30 | 1,500 | 18,450 | 65,104 | 66.6 K to 65.1 K (-2.25 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.31 | 3,100 | 38,161 | 66,604 | 69.7 K to 66.6 K (-4.45 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.32 | 4,300 | 52,976 | 69,704 | 74 K to 69.7 K (-5.81 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.33 | 500 | 6,165 | 74,004 | 74.5 K to 74 K (-0.67 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.34 | 196 | 2,419 | 74,504 | 74.7 K to 74.5 K (-0.26 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.36 | 200 | 2,472 | 74,700 | 74.9 K to 74.7 K (-0.27 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.40 | 300 | 3,720 | 74,900 | 75.2 K to 74.9 K (-0.40 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.41 | 400 | 4,964 | 75,200 | 75.6 K to 75.2 K (-0.53 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.42 | 2,200 | 27,324 | 75,600 | 77.8 K to 75.6 K (-2.83 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.43 | 2,200 | 27,346 | 77,800 | 80 K to 77.8 K (-2.75 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.44 | 500 | 6,220 | 80,000 | 80.5 K to 80 K (-0.62 %) |
Jan 05 2007 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 80,500 | 53 K to 80.5 K (+51.89 %) |
Dec 14 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 5,000 | 34,200 | 292,000 | |
Dec 14 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 5,000 | 34,200 | 53,000 | 48 K to 53 K (+10.42 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 264,500 | |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.86 | 1,000 | 12,860 | 53,000 | 54 K to 53 K (-1.85 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.87 | 1,000 | 12,870 | 54,000 | 55 K to 54 K (-1.82 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.88 | 8,500 | 109,480 | 55,000 | 63.5 K to 55 K (-13.39 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.92 | 2,000 | 25,840 | 63,500 | 65.5 K to 63.5 K (-3.05 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.93 | 4,000 | 51,720 | 65,500 | 69.5 K to 65.5 K (-5.76 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.94 | 3,000 | 38,820 | 69,500 | 72.5 K to 69.5 K (-4.14 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.95 | 1,000 | 12,950 | 72,500 | 73.5 K to 72.5 K (-1.36 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.96 | 2,000 | 25,920 | 73,500 | 75.5 K to 73.5 K (-2.65 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.97 | 1,000 | 12,970 | 75,500 | 76.5 K to 75.5 K (-1.31 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.98 | 2,000 | 25,960 | 76,500 | 78.5 K to 76.5 K (-2.55 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 13.00 | 2,000 | 26,000 | 78,500 | 80.5 K to 78.5 K (-2.48 %) |
Dec 22 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 80,500 | 53 K to 80.5 K (+51.89 %) |
Dec 11 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 297,000 | |
Dec 11 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.58 | 27,500 | 345,950 | 48,000 | 75.5 K to 48 K (-36.42 %) |
Dec 11 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 75,500 | 48 K to 75.5 K (+57.29 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 324,500 | |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.94 | 5,500 | 71,170 | 48,000 | 53.5 K to 48 K (-10.28 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.95 | 9,000 | 116,550 | 53,500 | 62.5 K to 53.5 K (-14.40 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.96 | 1,000 | 12,960 | 62,500 | 63.5 K to 62.5 K (-1.57 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.97 | 1,000 | 12,970 | 63,500 | 64.5 K to 63.5 K (-1.55 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.99 | 4,000 | 51,960 | 64,500 | 68.5 K to 64.5 K (-5.84 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 13.00 | 3,000 | 39,000 | 68,500 | 71.5 K to 68.5 K (-4.20 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 13.01 | 4,000 | 52,040 | 71,500 | 75.5 K to 71.5 K (-5.30 %) |
Nov 17 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 75,500 | 48 K to 75.5 K (+57.29 %) |
Nov 14 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 30,000 | 205,200 | 352,000 | |
Nov 14 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 30,000 | 205,200 | 48,000 | 18 K to 48 K (+166.67 %) |
Nov 03 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 382,000 | |
Nov 03 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 13.04 | 27,500 | 358,600 | 18,000 | 45.5 K to 18 K (-60.44 %) |
Nov 03 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 6.84 | 27,500 | 188,100 | 45,500 | 18 K to 45.5 K (+152.78 %) |
Oct 20 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Option Exercise | M | 6.84 | 27,500 | 188,100 | 409,500 | |
Oct 20 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Sell | S | 12.36 | 27,500 | 339,900 | 18,000 | 45.5 K to 18 K (-60.44 %) |
Oct 20 2006 | HGSI | HUMAN GENOME SCIEN ... | DAVIS JAMES H | Exec. VP, Gen Couns ... | Buy | M | 0.00 | 27,500 | 0 | 45,500 | 18 K to 45.5 K (+152.78 %) |